ecolog
studi
time
seri
rsv
monthli
posit
sampl
test
use
influenza
sentinel
surveil
system
sivepgrip
sivepflu
purpos
identifi
season
pattern
five
region
brazil
tempor
trend
rate
monthli
hospitalis
bronchiol
pneumonia
infant
year
age
region
period
also
analys
five
administr
region
brazil
chosen
local
studi
present
differ
socioeconom
environment
pattern
may
influenc
viru
circul
climat
midwest
region
inhabit
predominantli
tropic
raini
season
novemb
march
monthli
rainfal
temperatur
rang
northeast
region
inhabit
semiarid
climat
interior
tropic
atlant
climat
near
coast
major
popul
concentr
monthli
rainfal
rang
low
temperatur
rang
monthli
averag
north
region
inhabit
equatori
climat
rainfal
throughout
year
monthli
rainfal
low
thermal
amplitud
averag
southeast
region
inhabit
predominantli
altitud
tropic
climat
rainfal
concentr
novemb
march
monthli
rainfal
slightli
higher
thermal
amplitud
monthli
averag
final
southern
region
inhabit
predominantli
subtrop
climat
rainfal
distribut
throughout
year
monthli
rainfal
lower
temperatur
may
septemb
monthli
averag
influenza
sentinel
surveil
system
data
sivepgrip
laboratori
data
obtain
sivepgrip
sentinel
surveil
unit
distribut
throughout
region
brazil
surveil
unit
record
least
five
sampl
nasophar
yngeal
secret
weekli
patient
influenzalik
ill
measur
fever
associ
sore
throat
andor
cough
without
age
group
distinct
sampl
process
use
indirect
immunofluoresc
iif
includ
test
influenza
b
parainfluenza
adenoviru
rsv
studi
variabl
includ
place
resid
age
posit
neg
iif
result
rsv
laboratori
posit
indic
calcul
use
result
iif
reaction
nasophar
yngeal
secret
sampl
monthli
posit
iif
reaction
rsv
rel
total
monthli
valid
test
ie
exclud
result
within
inadequ
sampl
enough
biolog
materi
improp
storag
correct
materi
sampl
inconclus
result
valid
result
region
number
sampl
low
freita
et
al
sampl
select
analysi
hospitalis
data
hospitalis
data
obtain
hospit
inform
system
ministri
health
includ
admiss
made
brazilian
public
health
system
hospitalis
authoris
data
includ
hospitalis
brazil
hospitalis
caus
possibl
associ
rsv
select
codifi
inform
system
rsvassoci
pneumonia
rsvassoci
acut
bronchiti
rsvassoci
acut
bronchiol
unspecifi
acut
bronchiol
follow
respect
code
intern
diseas
classif
hospitalis
rate
calcul
divid
number
admiss
infant
less
year
old
aforement
caus
annual
popul
age
rang
estim
brazilian
institut
geographi
statist
hospitalis
popul
data
obtain
informat
depart
brazilian
public
health
system
time
seri
wavelet
fourier
analysi
initi
plot
made
visualis
time
paramet
season
trend
iif
posit
proport
nasopharyng
secret
laboratori
data
hospitalis
rate
analys
use
wavelet
techniqu
identifi
period
pattern
rsv
occurr
associ
morbid
wavelet
analysi
provid
inform
timescal
domain
stationari
nonstationari
event
allow
simultan
localis
time
high
low
frequenc
subtl
time
pattern
occurr
phenomena
differ
natur
detect
well
chang
period
wavelet
analysi
permit
infer
regard
way
continu
variabl
relat
differ
frequenc
whether
relationship
chang
time
torrenc
compo
cazel
et
al
algorithm
describ
torrenc
compo
avail
free
softwar
use
alonso
mccormick
analysi
allow
establish
whether
specif
period
phenomenon
stationari
frequenc
basic
assumpt
requir
fourier
analysi
next
laboratori
hospitalis
data
analys
fourier
time
seri
decomposit
use
sinusoid
harmon
annual
semiannu
cycl
fourier
analysi
consid
everi
period
period
stabl
frequenc
throughout
time
method
allow
analys
signal
system
decomposit
period
function
converg
trigonometr
seri
sin
co
case
allow
identifi
time
annual
biannual
peak
time
seri
analys
multipl
linear
regress
possibl
occurr
season
heterogen
within
administr
region
verifi
fourier
analysi
individu
hospitalis
data
state
sinc
sole
purpos
studi
analysi
season
secular
trend
mortal
hospitalis
correct
mean
polynomi
regress
improv
regress
fit
analysi
rsv
transmiss
annual
season
probabl
annual
station
greater
rsv
circul
defin
base
laboratorybas
posit
indic
sampl
indic
monthli
posit
samplestot
monthli
valid
sampl
use
defin
annual
season
rsv
five
consecut
month
higher
iif
posit
observ
definit
consist
prophylaxi
five
consecut
monthli
dose
palivizumab
recommend
brazilian
pediatr
societi
sbp
criterion
minor
chang
use
studi
rsv
influenza
analysi
monthli
weekli
data
shown
adequ
studi
season
chiu
et
al
bloomfeshbach
et
al
fourier
wavelet
analysi
perform
use
matlab
mathwork
inc
softwar
alonso
mccormick
statist
analysi
perform
use
spss
v
spss
inc
chicago
il
softwar
plot
construct
use
microsoft
offic
microsoft
corpor
research
approv
research
ethic
committe
faculti
medic
scienc
univers
campina
number
sampl
nasopharyng
secret
collect
confid
interv
ci
posit
rsv
number
sampl
collect
children
year
old
ci
posit
rsv
ratio
posit
result
iif
assay
age
group
year
old
five
region
shown
tabl
season
time
seri
wavelet
fourier
analysi
wavelet
analysi
permit
identifi
strong
tendenc
rsv
annual
cycl
region
countri
addit
one
suspect
lower
second
wave
peak
especi
earli
year
seri
unstabl
statist
signific
present
fig
evid
may
indic
biannual
semiannu
period
six
month
main
peak
second
peak
evid
north
midwest
region
specif
year
fig
shown
fig
season
pattern
evidenc
wavelet
irregular
may
due
small
number
monthli
sampl
annual
cycl
pattern
small
peak
appear
month
also
observ
fig
correspond
hospitalis
rate
bronchiol
pneumonia
stabl
annual
activ
pattern
identifi
use
wavelet
allow
analysi
mean
fourier
decomposit
complet
time
seri
year
rsv
season
analysi
fourier
decomposit
time
seri
assay
result
allow
identifi
region
differ
greater
activ
period
distinct
region
brazil
rsv
peak
occur
north
midwest
region
second
week
april
peak
northeast
first
week
may
peak
southeast
begin
april
south
first
week
june
peak
tabl
ii
season
fourier
decomposit
analysi
monthli
rate
hospitalis
rsvassoci
bronchiol
pneumonia
show
similar
result
compar
result
posit
seri
assay
region
tabl
ii
gener
criteria
mutual
consist
match
result
transmiss
peak
annual
season
analysi
appropri
date
start
immunoprophylaxi
palivizumab
region
brazil
compar
recent
indic
brazilian
ministri
health
tabl
iii
differ
month
suggest
begin
therapi
palivizumab
southeast
midwest
region
compar
brazilian
offici
guidelin
analysi
data
collect
sivepgrip
year
show
clear
season
region
brazil
region
differ
period
higher
viral
activ
probabl
rsv
season
period
identifi
sampl
test
use
iif
hospitalis
data
show
similar
result
although
etiolog
diagnosi
bronchiol
alway
routin
perform
brazilian
hospit
believ
rsv
respons
total
number
case
syndrom
children
year
old
nair
et
al
thu
consid
diagnosi
bronchiolithi
pneumonia
due
rsv
viral
circul
marker
sever
studi
demonstr
strong
correl
hospitalis
bronchiol
pneumonia
caus
rsv
viral
circul
rsv
includ
use
hospitalis
data
code
compat
symptom
caus
rsv
way
valid
laboratori
surveil
data
light
et
al
panozzo
et
al
hampp
et
al
use
syndorm
surveil
besid
valid
laboratori
surveil
data
enabl
identif
underreport
delay
report
observ
trend
occurr
diseas
freita
et
al
van
den
wijngaard
et
al
accordingli
season
match
found
laboratori
syndrom
surveil
indic
compat
may
valid
result
secondari
peak
seem
artifact
great
interest
studi
rsv
season
order
develop
appropri
prescript
palivizumab
administr
well
health
care
action
vieira
et
al
paiva
et
al
hayn
et
al
brazil
palivizumab
recommend
base
first
studi
regard
rsv
season
mainli
perform
south
southeast
state
anvisa
brazilian
ministri
health
includ
palivizumab
drug
freeli
distribut
brazilian
public
health
system
use
prematur
babi
gestat
age
less
equal
week
infant
less
year
old
chronic
lung
diseas
congenit
heart
diseas
demonstr
hemodynam
repercuss
everi
state
region
establish
optim
period
start
use
immunobiolog
account
region
climat
specif
epidemiolog
evid
ms
recent
revis
guidelin
ministri
health
propos
readjust
period
provis
immunobiolog
differ
region
countri
ms
result
reinforc
revis
provis
palivizumab
differ
region
suggest
other
studi
brazil
vieira
et
al
paiva
et
al
other
region
panozzo
et
al
blomfeshbach
et
al
result
period
avail
palivizumab
midwest
southeast
januari
match
exactli
suggest
ministri
health
februari
although
differ
one
month
dens
popul
region
readjust
immunis
schedul
palivizumab
aim
ensur
protect
higher
risk
children
avoid
wast
expens
immunobiolog
addit
ascertain
optim
time
prophylaxi
rsv
schedul
nonpharmacolog
intervent
interfer
transmiss
rsv
prevent
campaign
among
popul
health
care
provid
plan
provis
pediatr
hospit
bed
strengthen
period
year
jefferson
et
al
cdc
limit
studi
indic
includ
fact
data
posit
rsv
obtain
inform
system
still
partial
heterogen
cover
variou
region
countri
addit
period
studi
sivepgrip
includ
virus
metapneumoviru
bocaviru
enteroviru
human
coronaviru
may
caus
similar
clinic
featur
nonetheless
analys
data
repres
inform
avail
sivepgrip
great
implic
public
health
polici
countri
anoth
limit
studi
low
mean
posit
found
test
depend
sever
factor
independ
epidemiolog
situat
qualiti
sampl
collect
transport
addit
sensit
test
use
furthermor
number
collect
sampl
allow
use
weekli
laboratori
result
separ
evalu
state
howev
hospitalis
data
bronchiol
pneumonia
due
rsv
suggest
region
discrep
aggreg
sampl
administr
region
lead
inaccur
generalis
sinc
consid
differ
variou
state
make
region
howev
reduc
number
collect
sampl
state
allow
separ
moreov
partial
analysi
state
data
perform
studi
show
similar
result
state
aggreg
region
hospitalis
rate
bronchiol
respiratori
diseas
associ
rsv
children
year
age
consid
indic
indirectli
reflect
risk
circul
rsv
commun
although
laboratori
confirm
clinic
condit
routin
hospit
care
countri
syndrom
surveil
bronchiol
may
consid
good
sentinel
indic
rsv
circul
brazil
result
time
seri
analysi
laboratori
posit
indic
hospitalis
reinforc
revis
adapt
provis
calendar
highcost
immunoprophylaxi
rsv
infect
prevent
campaign
differ
region
brazil
